Table 3.
Participants’ assessment of topics covered: phase I
| Mean (SD*) | |
|---|---|
| Participants’ personal perspectives | |
| Topic | |
| Familiarity with PCOR and CER | 7.9/10 (1.5) |
| Importance of incorporating genetic information into CER | 8.0/10 (0.5) |
| Interest level in using genetic information in CER studies | 7.9/10 (0.6) |
| Participants’ assessment of educational aspect of the project | |
| Approval of the topics covered | 100% |
| Overall clarity of presentations | 8.8/10 (0.4) |
| Topics with the highest ratings | |
| Patient personal stories | 9.3/10 (1.1) |
| Examples of electronic medical record systems | 8.9/10 (1.1) |
| Overview of the ethical issues and genetic testing | 8.8/10 (1.0) |
| Overview of existing resources (PCORnet, eMERGE) | 8.8/10 (1.0) |
| Examples of genetic research done by our CAB members (scientists) | 8.8/10 (1.3) |
| Precision Medicine Initiative | 8.8/10 (1.2) |
Participants’ responses are based on a scale from “0- Strongly disagree” to “10- Strongly agree”
CAB community advisory board, CER comparative effectiveness research, SD standard deviation, PCOR patient-centered outcomes research
*SD equals the mean SD across groups